FundedIQ
Biotechnology

Reprogram Biosciences: Funding, Investors & Team (Oct 2026)

Reprogram Biosciences is a biotechnology company that develops cancer treatment with cell reprogramming technology.

reprogrambio.com LinkedIn San Francisco, United States 1-10 employees
Biopharma Biotechnology Life Science
Total raised
$5.0M
Rounds
1
Latest
Seed
May 2026

Reprogram Biosciences has raised $5.0M across 1 funding round on record, the most recent a Seed of $5.0M announced in May 2026.

That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Reprogram Biosciences Company Profile and Key Stats

Total funding raised
$5.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$5.0M in May 2026
Employees
1-10
reported band
Headquarters
San Francisco, United States

Latest funding round on record: May 2026.

Reprogram Biosciences Funding Rounds

Date
Round
Amount
Seed
$5.0M

Reprogram Biosciences Founders and Leadership Team

Name
Role
Contact
Rustam Esanov
Founder
Locked

Contact details for the Reprogram Biosciences team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.

Start 14-day free trial →

Reprogram Biosciences Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M
17,153
$3.1M

Reprogram Biosciences' latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Reprogram Biosciences in Biotechnology and San Francisco

Companies Similar to Reprogram Biosciences

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Reprogram Biosciences Funding FAQs

What does Reprogram Biosciences do?

Reprogram Biosciences is a biotechnology company that develops cancer treatment with cell reprogramming technology.

How much funding has Reprogram Biosciences raised?

Reprogram Biosciences has raised $5.0M across 1 round on record. The most recent is a Seed of $5.0M announced in May 2026.

When did Reprogram Biosciences last raise funding?

Reprogram Biosciences' most recent funding round on record is a Seed of $5.0M, announced in May 2026.

Who founded Reprogram Biosciences?

FundedIQ lists Rustam Esanov (Founder) at Reprogram Biosciences.

Where is Reprogram Biosciences headquartered?

Reprogram Biosciences is based in San Francisco, California, United States.

How many employees does Reprogram Biosciences have?

Reprogram Biosciences is in the 1-10 employee band.

How does Reprogram Biosciences' funding compare to other Biotechnology startups?

Reprogram Biosciences' latest round of $5.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Reprogram Biosciences Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Reprogram Biosciences is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.